May 11, 2021
Business News

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Acadia Pharmaceuticals Inc. (ACAD) on Behalf of Investors


LOS ANGELES–()–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Acadia Pharmaceuticals Inc. (“Acadia” or the “Company”) (NASDAQ: ACAD) investors concerning the Company’s possible violations of the federal securities laws.

If you suffered a loss on your Acadia investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/acadia-pharmaceuticals-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at



Click here to view the original article.

Related Posts

You might also like ...

Acorio To Speak on Strategy, Roadmaps, and Insight Data at ServiceNow Knowledge 2021
Vim Wins “Best Overall Health Informatics Solution” in 2021 MedTech Breakthrough Awards Program
Multiple Texas State, Local Governments and Education Institutions Modernize with GTY Technology Solutions for Digital Transformation